DE60132443D1 - In lebenden zielzellen - Google Patents

In lebenden zielzellen

Info

Publication number
DE60132443D1
DE60132443D1 DE60132443T DE60132443T DE60132443D1 DE 60132443 D1 DE60132443 D1 DE 60132443D1 DE 60132443 T DE60132443 T DE 60132443T DE 60132443 T DE60132443 T DE 60132443T DE 60132443 D1 DE60132443 D1 DE 60132443D1
Authority
DE
Germany
Prior art keywords
target cells
living target
living
titer
diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60132443T
Other languages
English (en)
Inventor
Manuel Vega
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nautilus Biotech SA
Original Assignee
Nautilus Biotech SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nautilus Biotech SA filed Critical Nautilus Biotech SA
Application granted granted Critical
Publication of DE60132443D1 publication Critical patent/DE60132443D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
DE60132443T 2000-05-09 2001-05-04 In lebenden zielzellen Expired - Lifetime DE60132443D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0005852A FR2808804B1 (fr) 2000-05-09 2000-05-09 Procede de determination du titre d'agents biologiques en temps reel dans des cellules cibles vivantes et ses applications
PCT/FR2001/001366 WO2001086291A1 (fr) 2000-05-09 2001-05-04 Procede de determination d'agents biologiques dans des cellules cibles vivantes

Publications (1)

Publication Number Publication Date
DE60132443D1 true DE60132443D1 (de) 2008-03-06

Family

ID=8849996

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60132443T Expired - Lifetime DE60132443D1 (de) 2000-05-09 2001-05-04 In lebenden zielzellen

Country Status (6)

Country Link
US (2) US20030175694A1 (de)
EP (1) EP1281081B1 (de)
AT (1) ATE384263T1 (de)
DE (1) DE60132443D1 (de)
FR (1) FR2808804B1 (de)
WO (1) WO2001086291A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7647184B2 (en) 2001-08-27 2010-01-12 Hanall Pharmaceuticals, Co. Ltd High throughput directed evolution by rational mutagenesis
US20030129203A1 (en) * 2001-08-27 2003-07-10 Nautilus Biotech S.A. Mutant recombinant adeno-associated viruses
US20060020396A1 (en) * 2002-09-09 2006-01-26 Rene Gantier Rational directed protein evolution using two-dimensional rational mutagenesis scanning
US20050202438A1 (en) * 2002-09-09 2005-09-15 Rene Gantier Rational directed protein evolution using two-dimensional rational mutagenesis scanning
ATE466085T1 (de) * 2002-09-09 2010-05-15 Hanall Pharmaceutical Co Ltd Protease-resistente modifizierte interferon alpha polypeptide
US7998930B2 (en) * 2004-11-04 2011-08-16 Hanall Biopharma Co., Ltd. Modified growth hormones
US20060251619A1 (en) * 2005-05-04 2006-11-09 Gilles Borrelly Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptides
US20080003202A1 (en) * 2006-03-28 2008-01-03 Thierry Guyon Modified interferon-beta (IFN-beta) polypeptides
WO2007149406A2 (en) * 2006-06-19 2007-12-27 Nautilus Technology Llc Modified coagulation factor ix polypeptides and use thereof for treatment
CN101678079B (zh) 2006-11-28 2013-12-25 韩诺生物制约株式会社 修饰的促红细胞生成素多肽及其治疗用途
EP2461162A1 (de) * 2010-12-03 2012-06-06 Texcell, . Verfahren zur Bestimmung des Titers von Viren durch Verwendung von infektiösen Standardsubstanzen
US11137337B2 (en) 2019-01-21 2021-10-05 Essen Instruments, Inc. Flow cytometry with data analysis for optimized dilution of fluid samples for flow cytometry investigation
US11709116B2 (en) 2020-02-04 2023-07-25 Sartorius Bioanalytical Instruments, Inc. Liquid flourescent dye concentrate for flow cytometry evaluation of virus-size particles and related products and methods

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2671559B1 (fr) * 1991-01-14 2002-09-27 Ct Nal Rech Scient Sequences codant pour le recepteur beta3-adrenergique murin, leur utilisation comme sondes et pour l'expression de peptides, vecteurs, hotes cellulaires contenant ledit vecteur, et applications desdits peptides.
US6183997B1 (en) * 1997-03-21 2001-02-06 Stratagene Polymerase enhancing factor (PEF) extracts PEF protein complexes isolated PEF proteins and methods for purifying and identifying same
ES2557997T3 (es) * 1997-09-05 2016-02-01 Genzyme Corporation Métodos para generar preparados de vectores AAV de título elevado sin virus auxiliar
FR2802645B1 (fr) 1999-12-16 2002-03-08 Meillat Roland Methode d'evaluation de la performance d'un ensemble d'agents biologiques dans des cellules cibles vivantes et ses applications
US7647184B2 (en) 2001-08-27 2010-01-12 Hanall Pharmaceuticals, Co. Ltd High throughput directed evolution by rational mutagenesis
US20030129203A1 (en) 2001-08-27 2003-07-10 Nautilus Biotech S.A. Mutant recombinant adeno-associated viruses
US20030224404A1 (en) 2002-02-25 2003-12-04 Manuel Vega High throughput directed evolution of nucleic acids by rational mutagenesis
ATE466085T1 (de) 2002-09-09 2010-05-15 Hanall Pharmaceutical Co Ltd Protease-resistente modifizierte interferon alpha polypeptide
US20060020396A1 (en) 2002-09-09 2006-01-26 Rene Gantier Rational directed protein evolution using two-dimensional rational mutagenesis scanning
US20050202438A1 (en) 2002-09-09 2005-09-15 Rene Gantier Rational directed protein evolution using two-dimensional rational mutagenesis scanning
US7998930B2 (en) 2004-11-04 2011-08-16 Hanall Biopharma Co., Ltd. Modified growth hormones

Also Published As

Publication number Publication date
EP1281081B1 (de) 2008-01-16
FR2808804B1 (fr) 2002-08-02
WO2001086291A1 (fr) 2001-11-15
US7349812B2 (en) 2008-03-25
US20060195268A1 (en) 2006-08-31
US20030175694A1 (en) 2003-09-18
FR2808804A1 (fr) 2001-11-16
ATE384263T1 (de) 2008-02-15
EP1281081A1 (de) 2003-02-05

Similar Documents

Publication Publication Date Title
CY1119742T1 (el) Βιολογικα συστηματα μεταφορας πολλαπλου-συστατικου
DE50214416D1 (de) Vermehrung von viren in zellkultur
DE60132443D1 (de) In lebenden zielzellen
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
TR200400149T2 (tr) Tümörlerin teşhisi ve tedavisi için mikroorganizmalar ve hücreler
EA200501772A1 (ru) Способы измерения экспрессии генов из фиксированного и залитого в парафин образца ткани
WO2002084250A3 (en) Methods for mass spectrometry detection and quantification of specific target proteins in complex biological samples
EA200870129A1 (ru) Человеческие антитела против il-23, композиции, способы и применение
WO2004035765A3 (en) Double-stranded rna structures and constructs, and methods for generating and using the same
AU3649397A (en) Precise efficacy assay methods for active agents including chemotherapeutic agents
DK0961780T3 (da) Proteinmarkörer for lungecancer og anvendelse deraf
WO2004011624A3 (en) Double stranded rna structures and constructs, and methods for generating and using the same
DK1187591T3 (da) IBD-associerede mikrobielle antigener og fremgangsmåder til at anvende samme
BRPI0412845A (pt) herpes-vìrus, uso de um vìrus, composição farmacêutica, e, método de tratamento de um tumor em um indivìduo em necessidade do mesmo
BR0207775A (pt) Lipossomos anfotéricos métodos para carregamento dos mesmos com ingredientes ativos e sua utilização
EP1322307A4 (de) Verfahren zur behandlung von zellproliferationen störungen und virusinfektionen
MXPA02012743A (es) Moleculas tipo il-17 y usos de las mismas.
WO2002063271A3 (en) Activity based probe analysis
DE60034966D1 (de) Auswertung von biologischen mitteln in lebenden zielzellen
ES2141249T3 (es) Procedimiento para la identificacion de celulas humanas y animales que presentan la capacidad para una proliferacion ilimitada o para una formacion de tumores.
DE60125537D1 (de) Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen
DE602004030824D1 (de) An der oberfläche befindliche campylobacter jejuni-polypeptide
EP1356076A4 (de) Verfahren und zusammensetzungen zur extraktion von proteinen aus zellen
ATE329638T1 (de) Vorrichtung, um in einem zielgebiet eines menschlichen oder tierischen körpers einen künstlichen isolierten kreislauf zu etablieren
DE59611307D1 (de) Nucleinsäure-moleküle codierend proteine, die die adhäsion von neisseria-zellen an humane zellen vermitteln

Legal Events

Date Code Title Description
8332 No legal effect for de